Potential therapeutic approaches in polymyositis and dermatomyositis
Authors:
J. Vencovský
Authors‘ workplace:
Revmatologický ústav, Praha
Published in:
Čes. Revmatol., 13, 2005, No. 1, p. 22-28.
Category:
Overview Reports
Overview
Therapeutic approaches based on controlled studies in patients with polymositis and dermatomyositis (PM/DM) are rather rare. It is caused by low incidence of these diseases as well as by deficiency of instruments to evaluate the treatment objectively and comparably. Pathogenic findings and number of immune abnormalities have led to the treatment with corticosteroids and immunosuppressive agents. Current therapeutic approaches are briefly mentioned in this short summary. New possibilities of biological therapy, namely TNF inhibition, depletion of B-cells, and trageting of complement system are discussed here more widely.
Key words:
polymyositis, dermatomyositis, anti-TNF, anti-CD20, anti-C5, treatment
Labels
Dermatology & STDs Paediatric rheumatology RheumatologyArticle was published in
Czech Rheumatology
2005 Issue 1
Most read in this issue
- Potential therapeutic approaches in polymyositis and dermatomyositis
- Chlamydia trachomatis and Chlamydophilla pneumoniae antibodies in a cohort of rheumatic patients
- Combined involvement of CNS and pituitary gland as a primary manifestation of Wegener’s granulomatosis
- Relevance of anti-nucleosome antibodies detected by enzyme – based immunoassays in lupus diagnosis. Comparative analysis of three commercial kits